Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR

Nature Cell Biology

Volumn 10, Issue 7, 2008, Pages 812-824

  Winter, Melanie ^a   Sombroek, Dirk ^a   Dauth, Ilka ^a   Moehlenbrink, Jutta ^a   Scheuermann, Karin ^a   Crone, Johanna ^a   Hofmann, Thomas G ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; DNA; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; PROTEIN P53; SERINE; SEVEN IN ABSENTIA HOMOLOGUE 1; UBIQUITIN PROTEIN LIGASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA PROTEIN COMPLEX; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE DISRUPTION; HUMAN; HUMAN CELL; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; UPREGULATION;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DNA DAMAGE; DNA-BINDING PROTEINS; ENZYME STABILITY; FIBROBLASTS; HUMANS; MICE; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; SERINE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 46449125390     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1743     Document Type: Article

References (50)

1. Rouse, J. & Jackson, S. P. Interfaces between the detection, signaling, and repair of DNA damage. Science 297, 547-551 (2002).
2. Zhou, B. B. & Elledge, S. J. The DNA damage response: Putting checkpoints in perspective. Nature 408, 433-439 (2000).
3. Shiloh, Y. ATM and related protein kinases: Safeguarding genome integrity. Nature Rev. Cancer 3, 155-168 (2003).
4. Kastan, M. B. & Lim, D. S. The many substrates and functions of ATM. Nature Rev. Mol. Cell Biol. 1, 179-186 (2000).
5. Abraham, R. T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196 (2001).
6. Kim, Y. H., Choi, C. Y., Lee, S. J., Conti, M. A. & Kim, Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 273, 25875-25879 (1998).
7. Hofmann. T. G. et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nature Cell Biol. 4, 1-10 (2002).
8. D'Orazi, G. et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nature Cell Biol. 4. 11-19 (2002).
9. Zhang, Q., Yoshimatsu, Y., Hildebrand, J., Frisch, S. M. & Goodman, R. H. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional co-repressor CtBP. Cell 115 177-186. (2003).
10. Pierantoni, G. M. et al. The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues. Biochem. Biophys. Res. Commun. 290 942-947. (2002).
11. Pierantoni, G. M. et al. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J. Clin. Invest. 117, 693-702 (2007).
12. Wei, G. et al. HIPK2 represses β-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc. Natl Acad. Sci. USA 104, 13040-13045 (2007)
13. Li, X. L. et al. Mutations of the HIPK2 gene in acute myeloid leukemia and myelo-dysplastic syndrome impair AML1- and p53-mediated transcription. Oncogene 26, 7231-7239(2007).
14. Oda, K. et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102, 849-862 (2000).
15. Hofmann, T. O. & Will, H. Body language: The function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 10, 1290-1299 (2003).
16. Moller, A. et al. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)- mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res. 63, 4310-4314. (2003).
17. Rui, Y. et al. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. EMBO J. 23 4583-4594 (2004).
18. Gresko, E. et al. Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J. 25. 1883-1894 (2006).
19. Grooteclaes, M. et al. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc. Natl Acad. Sci. USA 100, 4568-4573 (2003).
20. Di Stefano, V., Rinaldo, C., Sacchi, A., Soddu, S. & D'Orazi, G. Homeodomain-interacting protein kinase-2, activity and-p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp. Cell Res. 293, 311-320 (2004).
21. Dauth, I., Kruger, J. & Hofmann, T. G. Homeodomain-Interacting Protein Kinase 2 Is the Ionizing Radiation-Activated p53 Serine 46 Kinase and Is Regulated by ATM. Cancer Res. 67, 2274-2279 (2007).
22. Hofmann, T. G., Jaffray, E., Stollberg, N., Hay, R. T. & Will, H. Regulation of homeo-domain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification. J. Biol. Chem. 280, 29224-29232 (2005).
23. Gemani. A. et al. SIAH-1 interacts with α-tubulin and degrades the kinesin kid by the proteasome pathway during mitosis. Oncogene 19, 5997-6006. (2000).
24. Reed, J. C. & Ely, K. R. Degrading liaisons: Siah structure revealed. Nature Struct. Biol. 9, 8-10. (2002).
25. Bruzzoni-Giovanelli, H. et al. SIAH-1 inhibits cell growth by altering the mitotic process. Oncogene 18, 7101-7109. (1999).
26. Fanelli, M. et al. The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome. J. Biol. Chem. 279, 5374-5379 (2004).
27. Matsuzawa, S., Takayama, S., Froesch, B. A., Zapata, J. M. & Reed, J. C. p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: Suppression by BAG-1. EMBO J. 17 2736-2747. (1998).
28. Matsuzawa, S. I. & Reed, J. C. Siah I, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol. Cell 7, 915-926. (2001).
29. Liu, J. et al. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell 7, 927-936. (2001).
30. Rinaldo, C. et al. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol. Cell 25, 739-750 (2007).
31. Montes de Oca Luna, R., Wagner, D. S. & Lozano, G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion af p53. Nature 378, 203-206 (1995).
32. House, C. M. et al. A binding motif for Siah ubiquitin ligase. Proc. Natl Acad. Sci. USA 100, 3101-3106 (2003).
33. Gresko, E., Moller, A., Roscic, A. & Schmitz, M. L. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability. Biochem. Biophys. Res. Commun. 329, 1293-1299 (2005).
34. Polekhina, G. et al. Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-α signaling. Nature Struct. Biol. 9 68-75. (2002).
35. Olkamura, S. et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. Cell 8, 85-94. (2001).
36. Brooks, C. L. & Gu, W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21, 307-315 (2006).
37. Fiucci, G. et al. Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter. Proc. Natl Acad. Sci. USA 101, 3510-3515 (2004).
38. Iwai. A. et al. Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates β-catenin activity in a p53-dependent manner. Oncogene 23, 7593-7600 (2004).
39. Oren, M. Decision making by p53: Life, death and cancer. Cell Death Differ. 10, 431-442. (2003).
40. Stiff, T. et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 25, 5775-5782 (2006).
41. Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152-9159 (2004).
42. Shreeram, S. et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol. Cell 23, 757-764 (2006).
43. Lu, X., Nannenga, B. & Donehower. L. A. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev. 19, 1162-1174 (2005).
44. Schmidt, R. L. et al. Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue. Cancer Res. 67, 11798-11810 (2007).
45. Hofmann, T. G., Stollberg, N., Schmitz, M. L. & Will, H. HIPK2 Regulates Transforming Growth Factor-β-incluced c-jun NH(2 -terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res. 63, 8271-8277 (2003).
46. Shiotani, B. et al. Involvement of the ATR- and ATM-dependent checkpoint respcnses in cell cycle arrest evoked by plerisin-1. Mol. Cancer Res. 4, 125-133 (2006).
47. Milovic-Holm, K., Krieghoff, E., Jensen, K., Will, H. & Hofmann, T. G. FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. EMBO J. 26, 391-401 (2007).
48. Hofmann, T. G., Hehner, S. P., Droge, W. & Schmitz, M. L. Caspase-dependent cleavage and inactivatioh of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription. Oncogene 19, 1153-1163. (2000).
49. Cliby, W. A. et al. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA damaging agents and defects in cell cycle checkpoints. EMBO J. 17, 159-169 (1998).
50. Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (1998).